학술논문
Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes : rationale and design of the ODYSSEY Outcomes trial
Document Type
TEXT
Author
Source
Subject
Language
English